This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Joannes Adrianus Schuurkes: Innovator in Pharmaceutical Chemistry
Introduction
Joannes Adrianus Schuurkes is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzamide derivatives. With a total of 2 patents, Schuurkes has established himself as a key figure in the development of new medicinal compounds.
Latest Patents
One of Schuurkes' latest patents is focused on a novel benzamide derivative, which is described in detail in his patent titled "Enterokinetic benzamide." This invention involves pharmaceutical compositions that comprise the novel compounds, processes for preparing these compounds and compositions, and their use as a medicine. Specifically, the invention addresses conditions involving decreased motility of the intestine, showcasing its potential therapeutic applications.
Career Highlights
Schuurkes is associated with Janssen Pharmaceutica NV, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to contribute to the advancement of medical science through innovative drug development. His expertise in pharmaceutical chemistry has been instrumental in creating effective treatments for various health conditions.
Collaborations
Throughout his career, Schuurkes has collaborated with several esteemed colleagues, including Georges H Van Daele, who is now deceased, and Jean-Paul R Bosmans. These collaborations have enriched his research and contributed to the success of his inventions.
Conclusion
Joannes Adrianus Schuurkes is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medicine. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
